Opaleye Management Inc. 13D/13G Filings for Grace Therapeutics, Inc. (GRCE)

Opaleye Management Inc. 13D and 13G filings for Grace Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-08-07
4:05 pm
Purchase
2026-08-0513GGRACE THERAPEUTICS, INC
GRCE
Opaleye Management Inc.2,748,392
13.070%
2,748,392increase
(New Position)
Filing